China based ophthalmic pharmaceutical company, Zhaoke Ophthalmology has united with US-based medical device manufacturer, Eyedetec Medical to distribute Eye Lipid Mobilizer (ELM) in several Asian regions.

Eyedetec Medical has a portfolio of products designed to combat dry eye disease (DED) including EyeGenie, a dry eye treatment mask. ELM is designed to relieve moderate and severe DED by stabilising the oil layer of the eye’s tear film. ELM reduces tear evaporation and normalises the ocular surface. Using a combination of heat delivery, resonant frequency stimulation, and neuromodulation to offer patients various treatment options.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The collaboration will bring these treatment solutions to China, Taiwan, South Korea, and the ASEAN countries. In the agreement, Zhaoke Ophthalmology will have the exclusive rights to register, import, promote, distribute, market, and sell ELM.

Eyedetec Medical have ran multiple clinical studies for the device and found it was easy for patients to learn and use for home therapy.

“With the ELM, we have reimagined dry eye treatment, and have created a solution that is remarkably effective, affordable, and convenient,” said said Dr. Barry J Linder, CEO of Eyedetec Medical. “As the incidence of evaporative dry eye disease continues to grow around the world, the markets in Greater China, South Korea, and ASEAN countries are especially attractive, with large numbers of tech savvy patients that want innovative treatments delivered in the comfort of their homes.”

Eyedetec Medical is preparing for ELM’s U.S. FDA premarket submission. Once cleared in the U.S., ELM will be the first and only physician-prescribed therapy that treats the root cause of dry eye disease at home. ELM is not currently commercially available for sale in the U.S.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact